Hepatocellular carcinoma (staging)

Changed by Jeremy Jones, 28 Dec 2016

Updates to Article Attributes

Title was changed:
Hepatocellular carcinoma (HCC(staging) staging
Body was changed:

Hepatocellular carcinoma (HCC) staging classifications supersede the typical typical TNM staging system seen in most other epithelial cancers.

The TNM staging system was found to not not be as prognostically useful for stratification of patients with hepatic cancers. Several substitute staging systems have arisen to guide therapy choice and prognosis for hepatocellular hepatocellular carcinoma:

Of these, the BCLC system is the one most often used in Western countries to guide treatment. 

In a related dimension, there are additional criteria for liver transplantation with HCC, which vary depending on one's institution:

Finally, in addition to these HCC therapy and prognostication prognostication models, models of hepatic dysfunction are a vital dimension in evaluating an individual patient's therapy options:

Overall models for a patient's general well-being are important too, such as 

Some of the staging systems (such as the BCLC system and the JIS) incorporate hepatic hepatic function and patient well-being variables into the staging system.

Pathology

Vascular invasion, both macroscopic and microscopic, is correlated with a high rate of recurrence, and plays plays an important role in most HCC staging systems. Microvascular invasion is determined on biopsy.

The importance of nodal metastases in HCC is not completely defined, but considered a late stage finding with poor prognosis.

Practical points

  • in patients with severe cirrhosis, the Child-Pugh score and MELD score may give a better idea of prognosis than an HCC staging classification
  • technical problems in in resection planning (e.g. a small tumor across the middle hepatic vein) influence overall prognosis

See also

  • -<p><strong>Hepatocellular carcinoma (HCC) staging</strong> classifications supersede the typical TNM staging system seen in most other epithelial cancers.</p><p>The TNM staging system was found to not be as prognostically useful for stratification of patients with hepatic cancers. Several substitute staging systems have arisen to guide therapy choice and prognosis for hepatocellular carcinoma:</p><ul>
  • -<li><a href="/articles/barcelona-clinic-liver-cancer-bclc-staging-classification">Barcelona-Clinic Liver Cancer (BCLC) staging system</a></li>
  • +<p><strong>Hepatocellular carcinoma (HCC) staging</strong> classifications supersede the typical TNM staging system seen in most other epithelial cancers.</p><p>The TNM staging system was found to not be as prognostically useful for stratification of patients with hepatic cancers. Several substitute staging systems have arisen to guide therapy choice and prognosis for hepatocellular carcinoma:</p><ul>
  • +<li><a href="/articles/barcelona-clinic-liver-cancer-bclc-staging">Barcelona-Clinic Liver Cancer (BCLC) staging system</a></li>
  • -<li><a href="/articles/milan-criteria-in-liver-tranplantation">Milan criteria</a></li>
  • +<li><a href="/articles/milan-criteria-in-liver-tranplantation-1">Milan criteria</a></li>
  • -</ul><p>Finally, in addition to these HCC therapy and prognostication models, models of hepatic dysfunction are a vital dimension in evaluating an individual patient's therapy options:</p><ul>
  • +</ul><p>Finally, in addition to these HCC therapy and prognostication models, models of hepatic dysfunction are a vital dimension in evaluating an individual patient's therapy options:</p><ul>
  • -</ul><p>Overall models for a patient's general well-being are important too, such as </p><ul><li><a href="/articles/ecog-performance-status">ECOG performance status</a></li></ul><p>Some of the staging systems (such as the BCLC system and the JIS) incorporate hepatic function and patient well-being variables into the staging system.</p><h4>Pathology</h4><p>Vascular invasion, both macroscopic and microscopic, is correlated with a high rate of recurrence, and plays an important role in most HCC staging systems. Microvascular invasion is determined on biopsy.</p><p>The importance of nodal metastases in HCC is not completely defined, but considered a late stage finding with poor prognosis.</p><h4>Practical points</h4><ul>
  • +</ul><p>Overall models for a patient's general well-being are important too, such as </p><ul><li><a href="/articles/ecog-performance-status">ECOG performance status</a></li></ul><p>Some of the staging systems (such as the BCLC system and the JIS) incorporate hepatic function and patient well-being variables into the staging system.</p><h4>Pathology</h4><p>Vascular invasion, both macroscopic and microscopic, is correlated with a high rate of recurrence, and plays an important role in most HCC staging systems. Microvascular invasion is determined on biopsy.</p><p>The importance of nodal metastases in HCC is not completely defined, but considered a late stage finding with poor prognosis.</p><h4>Practical points</h4><ul>
  • -<li>technical problems in resection planning (e.g. a small tumor across the middle hepatic vein) influence overall prognosis</li>
  • +<li>technical problems in resection planning (e.g. a small tumor across the middle hepatic vein) influence overall prognosis</li>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.